TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 107 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 1.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $14,000 | -87.3% | 30,000 | -63.4% | 0.00% | -100.0% |
| Q1 2019 | $110,000 | -0.9% | 82,000 | -16.3% | 0.00% | 0.0% |
| Q4 2018 | $111,000 | -58.1% | 98,000 | +2.1% | 0.00% | -50.0% |
| Q3 2018 | $265,000 | -39.2% | 96,000 | -21.3% | 0.00% | -33.3% |
| Q2 2018 | $436,000 | +14.4% | 122,000 | -1.6% | 0.00% | +50.0% |
| Q1 2018 | $381,000 | -51.2% | 124,000 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $781,000 | -10.8% | 124,000 | -3.1% | 0.00% | -20.0% |
| Q3 2017 | $876,000 | -4.1% | 128,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $913,000 | -22.4% | 128,000 | 0.0% | 0.01% | -28.6% |
| Q1 2017 | $1,176,000 | +127.9% | 128,000 | 0.0% | 0.01% | +133.3% |
| Q4 2016 | $516,000 | +5.3% | 128,000 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $490,000 | -5.0% | 128,000 | +6.7% | 0.00% | 0.0% |
| Q2 2016 | $516,000 | +89.0% | 120,000 | +103.4% | 0.00% | +50.0% |
| Q1 2016 | $273,000 | -45.6% | 59,000 | +18.0% | 0.00% | -33.3% |
| Q4 2015 | $502,000 | +34.6% | 50,000 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $373,000 | -94.6% | 50,000 | -65.8% | 0.00% | -94.4% |
| Q2 2015 | $6,926,000 | -28.7% | 146,000 | -44.9% | 0.04% | -26.5% |
| Q1 2015 | $9,709,000 | +288.0% | 264,990 | +320.6% | 0.05% | +308.3% |
| Q4 2014 | $2,502,000 | +62.9% | 63,000 | -18.2% | 0.01% | +50.0% |
| Q3 2014 | $1,536,000 | +184.4% | 77,000 | +92.5% | 0.01% | +166.7% |
| Q2 2014 | $540,000 | – | 40,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 1,048,642 | $3,219,000 | 0.50% |
| Virtus ETF Advisers LLC | 130,920 | $402,000 | 0.35% |
| 683 Capital Management, LLC | 600,000 | $1,842,000 | 0.16% |
| Tekla Capital Management LLC | 859,322 | $2,638,000 | 0.10% |
| DOW CHEMICAL CO /DE/ | 65,000 | $200,000 | 0.07% |
| Alambic Investment Management, L.P. | 115,834 | $356,000 | 0.05% |
| A.R.T. Advisors, LLC | 262,896 | $807,000 | 0.03% |
| Candriam S.C.A. | 520,613 | $1,598,000 | 0.03% |
| Man Group plc | 1,674,341 | $5,140,000 | 0.02% |
| Baker Brothers Advisors | 935,000 | $2,870,000 | 0.02% |